Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism.
EMBO Mol Med
2019
11
6
Reply to: Safety of dopamine agonists for treating restless legs syndrome.
Mov Disord
2019
34
1
150-151
Role of MEIS1 in restless legs syndrome: From GWAS to functional studies in mice.
Adv Pharmacol
2019
84
175-184
Recessive variants in ZNF142 cause a complex neurodevelopmental disorder with intellectual disability, speech impairment, seizures, and dystonia.
Genet Med
2019
21
11
2532-2542
Reply to: A note on rotigotine for restless legs syndrome after renal transplantation.
Mov Disord
2019
34
1
152-153
Biological and clinical insights from genetics of insomnia symptoms.
Nat Genet
2019
51
3
387-393
Bi-allelic variants in RNF170 are associated with hereditary spastic paraplegia.
Nat Commun
2019
10
1